The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.
People on integrase inhibitors found to gain more weight on average than those on other treatment regimens
Despite the country’s successful treatment programme, modelling suggests the rate of new infections is likely to rise – unless prevention is strengthened and groups such as migrants included.
South African trial finds 90% of people receiving rapid viral load testing were virally suppressed and in care after 12 months, compared to 76% who waited for tests.
HIV incidence more than halved among people from fishing communities in Lake Victoria, Uganda, after rapid expansion of HIV services.
Routine point‐of‐care viral load monitoring achieves high testing coverage rates and same-day delivery of results in decentralised clinics.
Innovative HIV service delivery models are well received and have the potential to improve health outcomes.
Second-line treatment failure in sub-Saharan Africa is a public health crisis we need to control.
New analysis reveals real-world impact of the national roll-out of ‘treat all’ guidelines on antiretroviral treatment uptake in sub-Saharan Africa.
Interviews with men in Côte d’Ivoire reveal radical differences in the perceptions of those who do and don’t access care.